Web Results

Coleman v. Miller


Coleman v. Miller, 307 U.S. 433 (1939) is a landmark decision of the United States Supreme ... et al. v. Miller, Secretary of the Senate of State of Kansas, et al.

Miller et al. v. Ghirardelli


Welcome to the Miller et al. v. Ghirardelli Website. IMPORTANT UPDATE: On February 20, 2015, the Court entered a Final Approval Order approving the ...

In re: Crescent City Estates, LLC - United States Court of Appeals for ...


Dec 7, 2009 ... GIANNASCA CRESCENT CITY, LLC; .... is a longstanding legal principle, see Key Tronic Corp. v. ..... See, e.g., 14B & 14C Charles Alan Wright, Arthur R. Miller, et al., Federal Practice and Procedure, §§ 3721-40 (4th ed. &.



Jun 8, 2009 ... McCRARY CRESCENT CITY, LLC, et al. ... Baltimore City against appellants, Edward V. Giannasca, II (“Giannasca”), Stuart Cornelius Fisher, ...

Enhancing Oral Vaccine Potency by Targeting Intestinal M Cells


Nov 11, 2010 ... In a study by Mann et al. .... In an interesting study by Giannasca et al. [106] .... Stowe J, Andrews N, Wise L, Miller E. Bell's palsy and parenteral inactivated ..... Manocha M, Pal PC, Chitralekha KT, Thomas BE, Tripathi V, et al.

Targeting surface-layer proteins with single-domain antibodies: a ...


May 5, 2015 ... Targeting SLPs with VHHs may be a viable therapeutic approach against C. difficile-associated disease. ... difficile virulence factors and are therapeutic targets (Giannasca and ... The LMW subunit is highly immunogenic (Pantosti et al . ...... Magrini V, Mardis ER, Gerding DN, Loo VG, Miller MA, Mulvey MR, ...

Full-Text PDF - MDPI.com


Sep 24, 2015 ... Yasmeen Vincent 1, Arif Manji 1, Kathleen Gregory-Miller 1 and Christine Lee 1 ... In a 2012 report by Lucado et al., there were 336,600 CDI-related ..... Fidaxomicin vs. vancomycin for Clostridium difficile infection: ... Sougioultzis, S.; Kyne, L.; Drudy, D.; Keates, S.; Maroo, S.; Pothoulakis, C.; Giannasca, P.J.;.

Clinical Management of Clostridium difficile-Associated Disease


Mark A. Miller. + Author .... A substantive review of this vaccine was recently published by Giannasca and Warny [41]. .... Loo VG,; Poirier L,; Miller MA,; et al.

The Intestinal Epithelial Barrier: Does It Become Impaired with Age ...


Frey A, Giannasca KT, Weltzin R, et al: Role of the glycocalyx in regulating access of ... Ma TY, Hollander D, Dadufalza V, et al: Effect of aging and caloric restriction on .... Garcia GG, Miller RA: Differential tyrosine phosphorylation of zeta chain ...

Vaccine adjuvants: Current state and future trends


Since the experiments of Glenny et al. alum salts, principally aluminium ..... Also V. cholerae and poliovirus strains can be used for oral immunization of heterologous antigens. ..... Taylor PJ, Miller CL, Pollock TM, Perkins FT, Westwood MA. .... Article | PubMed | ISI | ChemPort |; Frey A, Giannasca KT, Weltzing R et al. Role of ...

More Info

Frequently Asked Questions - Miller et al. v. Ghirardelli


Frequently Asked Questions. Helpful Hint: Using the general subject of your question may provide the best search results. For example, enter the word " hearing" ...

Judge Frank J. Bailey's Opinions - UNITED STATES BANKRUPTCY ...


DeGiacomo v. First Call Mortgage Company, Inc. et al ... 03/30/2015. Ojeda v. Bicalho. 11-01340. 03/30/2015. Lassman v. Santosuosso et al ... Anthony U. Giannasca .... Arroyo v. United States of America et al. 09-01229. 03/30/2012. Miller v.

Clostridium difficile Infection Prevention: Biotherapeutics ...


Jan 25, 2012 ... The key paper (Tedesco et al., 1974) published in 1974 suggested an .... The V. cholerae vector was recoverable from the rabbit ileum for up to 5 days .... Aboudola S, Kotloff KL, Kyne L, Warny M, Kelly EC, Sougioultzis S, Giannasca PJ , .... Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, ...